Utilizing Smart Devices to Identify New Phenotypical Characteristics in Movement Disorders
NCT ID: NCT03638479
Last Updated: 2022-06-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
513 participants
OBSERVATIONAL
2019-01-08
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using Wearable and Mobile Data to Diagnose and Monitor Movement Disorders
NCT04231487
Free-living Monitoring of Parkinson's Disease Using Smart Objects
NCT05830253
Movement Disorder Quantification Algorithm Development
NCT01534650
Capturing Parkinson's Disease Medication Side Effects During Daily Activities
NCT01429207
Development of Digital Diagnostic Devices for Parkinson's Disease
NCT06663826
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The system will be applied and analyzed within an experimental and observational setting and only captures from patients, which have received informed consent. Within the study period, the SDS is not intended as clinical diagnostic support for physicians and will be not be used as medical device.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Parkinson's Disease
Participant's diagnosed with Parkinson's Disease
Data Capture
This is no intervention. Participants of all groups will receive data Capture with smartphones, smartwatches and tablets.
Essential Tremor
Participant's diagnosed with Essential Tremor or other Movement Disorders
Data Capture
This is no intervention. Participants of all groups will receive data Capture with smartphones, smartwatches and tablets.
No Parkinson's Disease and No Essential Tremor
Participant's with no diagnosis of PD, ET or other Movement Disorders
Data Capture
This is no intervention. Participants of all groups will receive data Capture with smartphones, smartwatches and tablets.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data Capture
This is no intervention. Participants of all groups will receive data Capture with smartphones, smartwatches and tablets.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Comparison group: Other movement disorders including atypical Parkinsonian disorders and healthy participants
Exclusion Criteria
* Skin-related conditions at one of the wrists or any other medical conditions that could harm the participant's health by wearing the smartwatch at both wrists.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universität Münster
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Julian Varghese
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julian Varghese, MD
Role: PRINCIPAL_INVESTIGATOR
WWU Münster, Institut für Medizinische Informatik
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of Medical Informatics, University of Münster
Münster, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Purk M, Fujarski M, Becker M, Warnecke T, Varghese J. Utilizing a tablet-based artificial intelligence system to assess movement disorders in a prospective study. Sci Rep. 2023 Jun 26;13(1):10362. doi: 10.1038/s41598-023-37388-3.
Varghese J, Niewohner S, Soto-Rey I, Schipmann-Miletic S, Warneke N, Warnecke T, Dugas M. A Smart Device System to Identify New Phenotypical Characteristics in Movement Disorders. Front Neurol. 2019 Jan 30;10:48. doi: 10.3389/fneur.2019.00048. eCollection 2019.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VA111809
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.